NAD+ Therapy: The Science Behind Cellular Rejuvenation

NAD+ has had a strange decade. It started as an obscure coenzyme that biochemistry students memorized for redox reactions, got absorbed into the longevity influencer circuit, and now sits behind a lot of glossy IV menus and supplement bottles. The hype is loud. The underlying biology is real and worth understanding, not because NAD+ is a fountain of youth, but because what it does inside your cells is foundational.

This is a working summary of what we know, what we don't, and how to think about NAD+ therapy without buying the marketing. We will cover the basics, the human evidence, the safety profile, and how we approach it at Nomi Beach Health.

What NAD+ actually is

NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme present in every living cell, and almost nothing inside you works without it. At the most basic level, NAD+ shuttles electrons during metabolism: it accepts a hydride to become NADH, then drops it off in the mitochondria to power ATP production. That redox cycle is foundational biology [1].

NAD+ is also a substrate, meaning enzymes consume it. Three families matter most:

• Sirtuins (SIRT1 through SIRT7) are NAD-dependent enzymes that regulate gene expression, mitochondrial biogenesis, DNA repair, and inflammation. They go quiet when NAD+ is low [1, 2].
• PARPs (poly-ADP-ribose polymerases) consume NAD+ to repair damaged DNA. Under chronic stress or inflammation, PARP demand rises and pulls NAD+ away from other uses [2].
• CD38 is a membrane enzyme that degrades NAD+. It rises with age and chronic inflammation, and it is one of the bigger reasons tissue NAD+ levels drop with age [3].

In short: NAD+ supports redox metabolism, DNA repair, and the enzymes that regulate stress responses. When supply tightens, those systems run with less margin.

Why NAD+ declines with age

Tissue NAD+ levels fall meaningfully between young adulthood and later life. This has been measured in skin, muscle, brain, and liver across multiple studies [2, 3]. The decline is not because we stop making NAD+. It is because demand goes up and clearance speeds up.

Three things tend to happen at once:

1. CD38 expression rises with chronic low-grade inflammation, sometimes called inflammaging. More CD38, more NAD+ chewed up [3].
2. PARP activity increases as DNA damage accumulates over decades. Every repair event burns NAD+ [2].
3. Salvage pathway efficiency drops. Cells recycle NAD+ from nicotinamide using an enzyme called NAMPT, and NAMPT activity tends to decline with age [2].

The net result is a cell with less of the coenzyme it needs to repair DNA, regulate gene expression, and run its mitochondria. The descriptive biology is solid. The leap from "NAD+ declines with age" to "raising NAD+ reverses aging" is where the evidence thins out, and we will get to that.

Forms of NAD+ therapy

There are four main ways to get more NAD+ raw material into your body. They are not interchangeable.

IV NAD+ infusion. A bag of saline mixed with 250 to 1,000 mg of NAD+, infused slowly over 2 to 4 hours. The drip has to run slow because pushing NAD+ fast produces a distinct, uncomfortable sensation: chest pressure, abdominal cramping, flushing. Slow it down and most people tolerate it well. IV produces the highest acute blood levels. What is less clear is how much intact NAD+ actually crosses cell membranes versus how much gets broken down to nicotinamide first and then re-synthesized inside cells [7].

IM or SubQ NAD+ injection. A smaller dose (50 to 200 mg) given as an injection. Easier and faster than an IV. Lower peak levels, but practical for ongoing maintenance.

Oral precursors: NR and NMN. Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are precursors your body converts to NAD+ through the salvage pathway. The strongest human pharmacokinetic data on raising blood NAD+ comes from oral NR and NMN trials [4, 5, 8]. By a wide margin, these are the most-studied options in humans.

Niacin and niacinamide. The original NAD+ precursors. Cheap, available, often forgotten. Niacin (nicotinic acid) raises NAD+ effectively but causes a strong flushing reaction at therapeutic doses. Niacinamide (nicotinamide) does not cause flushing but inhibits sirtuins at high doses, which is a real tradeoff [9].

A note on intact delivery. When you take NR, NMN, or infused NAD+, much of it is broken down to nicotinamide in the gut, liver, and bloodstream before it reaches tissues. Cells then rebuild NAD+ from those simpler pieces. So cross-form dose comparisons are not apples to apples, and the pharmacokinetics matter. Blood NAD+ rising is not the same as tissue NAD+ rising in the heart, brain, or muscle [7, 10].

What the human evidence does and doesn't say

Most of the dramatic claims you read online (reversed aging, restored mitochondrial function, extended lifespan) come from rodent studies. Mice are not small humans. They share a lot of biology, but their NAD+ metabolism, lifespan dynamics, and disease patterns differ enough that translation has been inconsistent [10]. When something works in mice and not in people, NAD+ has been on that list more than once.

Here is what the human trials have actually shown:

• NR raises blood NAD+ reliably. A 2018 trial in 30 healthy middle-aged and older adults gave 1,000 mg of NR daily for six weeks and saw blood NAD+ roughly double, with a clean safety profile [4]. A longer 2019 trial in 140 overweight adults confirmed safety and NAD+ elevation over four to eight weeks [6].
• NMN improved muscle insulin sensitivity in one small trial of prediabetic women. A 2021 trial of 25 postmenopausal women with prediabetes found 250 mg of NMN daily for 10 weeks improved skeletal muscle insulin sensitivity. It did not change body weight, blood pressure, or inflammatory markers [5]. One trial, small sample, encouraging signal.
• NMN raised blood NAD+ in healthy adults safely. A small 2020 study in 10 healthy Japanese men found single doses of NMN up to 500 mg were safe and raised NAD+ metabolites [8].
• Human IV NAD+ pharmacokinetics are barely characterized. The most-cited human IV study is a pilot in 8 men tracking plasma and urine NAD+ metabolites during and after a 6-hour infusion [7]. Informative, but small, and it does not establish clinical outcomes.

What the human data does not yet show, despite frequent claims:

• Reversal of biological aging in any validated sense
• Lifespan extension
• Cure or reversal of dementia, Parkinson disease, or other neurodegenerative conditions
• Replacement of standard treatment for any disease

That is not a dismissal. It is a fair read of the evidence as of early 2026. Trials are getting larger and longer, and several phase 2 studies are underway in metabolic and neurodegenerative disease. We will know more in a few years.

Possible benefits being studied

These are areas where the human signal is encouraging but not conclusive:

• Metabolic health. Better insulin sensitivity and lipid handling have shown up in small trials, especially with NMN in prediabetic populations [5]. Promising. Not enough to call it a treatment.
• Exercise capacity and recovery. A few small studies suggest NR may help muscle strength and recovery in older adults. Effect sizes are modest, and the literature is not consistent [4, 10].
• Neuroprotection and cognition. The sirtuin and PARP biology gives a clean mechanistic rationale. Human cognition trials so far are small and mixed. We don't have great human data here yet.
• Mood and energy. Plenty of patient-reported benefit, very limited rigorous data. Placebo response in this space is real.
• Cardiovascular markers. Early signals on blood pressure and arterial stiffness from NR [4]. Needs replication in larger trials.

If a clinic tells you NAD+ "reverses aging," they are ahead of the data. If they tell you it may support metabolic and mitochondrial function and may help with recovery and energy in some patients, that's roughly in line with what we actually know.

Safety profile

NAD+ and its precursors have looked clean at studied doses. Across multiple trials, NR at 300 to 1,000 mg daily and NMN at 250 to 500 mg daily have not produced serious adverse events at higher rates than placebo [4, 5, 6, 8]. Common, mild side effects: nausea, headache, GI discomfort.

Specific to delivery:

• High-dose niacin (nicotinic acid) causes flushing, itching, and warmth. Manageable with slow titration, but uncomfortable [9].
• IV NAD+ can cause chest pressure, abdominal cramping, anxiety, and flushing if it runs too fast. Slowing the drip almost always resolves it. A little infusion-site soreness is normal.
• IM NAD+ injections can sting briefly at the injection site.

Theoretical concerns worth naming:

• NAD+ and cancer. Cancer cells, like all cells, use NAD+. Whether boosting NAD+ accelerates tumor growth in someone with active or undiagnosed cancer is genuinely unknown. Most clinicians, including us, hold NAD+ therapy during active cancer treatment.
• Methylation load. High doses of nicotinamide can consume methyl groups, which matters for some people with MTHFR variants or other methylation issues. Adjustable with supplementation.
• Drug interactions. Limited data. We are cautious with medications that affect liver enzymes or methylation.

Who is and isn't a candidate

Generally appropriate:

• Healthy adults who want to support energy, recovery, and metabolic resilience
• People with documented signs of mitochondrial fatigue, post-viral fatigue, or persistent low energy after a standard workup
• People in a structured longevity program with baseline labs

Pause or avoid:

• Pregnancy and breastfeeding (insufficient safety data)
• Active cancer or recent cancer treatment without oncologist input
• Severe liver or kidney disease
• Active uncontrolled cardiovascular disease
• Known hypersensitivity to NAD+ products

NAD+ therapy is not a substitute for sleep, training, protein intake, or addressing root metabolic issues. The people who get the most out of it are the ones who already have those basics in place.

What an NAD+ IV visit looks like

You arrive, we review symptoms and any new medications, and we set the IV. A full-dose NAD+ infusion runs slowly, usually 2 to 4 hours for 500 to 1,000 mg. Most people sit in a comfortable chair with a book, laptop, or phone. We start the drip slow, then increase the rate as tolerated.

Sensation varies. Some people feel nothing beyond mild warmth. Others get chest pressure, a flushed face, or stomach discomfort if the rate is too fast. We slow the drip until it settles. We monitor blood pressure and pulse, keep water and snacks handy, and watch for any reactions.

After the infusion, most people feel normal or a little tired. Some report a clean, focused energy over the next 24 to 72 hours. Others notice nothing acutely. We schedule the next session based on your protocol, typically a loading phase followed by spaced maintenance. IM injections take five minutes and slot in between infusions for patients who want steady support.

NAD+ at Nomi Beach Health

Our NAD+ menu is built around what makes clinical sense, not what looks impressive on a price list:

• Full-dose IV NAD+ (500 to 1,000 mg) for loading or higher-acuity cases
• Maintenance IV NAD+ (250 to 500 mg) for regular-cadence patients
• IM and SubQ NAD+ injections for in-between maintenance and patients who do not want IVs
• Oral NR and NMN as part of a structured longevity supplement plan

We see patients in person at our North Miami Beach and Aventura locations, and we offer telehealth consults across the states our providers are licensed in. The intake is straightforward: a video or in-person consult, baseline labs (fasting metabolic panel, hormone panel, inflammatory markers, and CBC at minimum), a review of medications and goals, and a written plan.

We are not going to oversell this. NAD+ therapy is one tool inside a practice that also covers hormone optimization, metabolic care, sleep, and basic preventive medicine. For some people it is meaningful. For others it is unnecessary, and we say so.

Closing thought

The biology is real. The hype is overstated. The honest move is to use NAD+ therapy where the human evidence supports it (metabolic resilience, recovery, mitochondrial support in selected patients) while staying skeptical of the bigger anti-aging claims until larger trials read out.

If you are curious whether NAD+ fits your goals, book a consult and we will walk through your labs, your history, and what would actually be useful. We would rather you do less and do it right than chase every trend on offer.